About miBiome Therapeutics
miBiome Therapeutics is a company based in Mumbai (India) founded in 2019 by Ravi Shroff and Gautam Das. It operates as a B2B. miBiome Therapeutics offers products and services including DNA Reading, Scientific Consulting, and Computational Analytics. miBiome Therapeutics operates in a competitive market with competitors including Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
- Headquarter Mumbai, India
- Founders Ravi Shroff, Gautam Das
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mibiome Therapeutics Llp
- Date of Incorporation 16 May, 2019
- Jurisdiction Jogeshwart West Mumbai, Maharashtra, India
-
Annual Revenue
$45.73 K (USD)0as on Mar 31, 2021
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miBiome Therapeutics
miBiome Therapeutics offers a comprehensive portfolio of products and services, including DNA Reading, Scientific Consulting, and Computational Analytics.
Sequences DNA for understanding life, disease, and environment.
Provides expert guidance on genomic sequencing processes.
Utilizes software for in-depth biological data interpretation.
Funding Insights of miBiome Therapeutics
Detailed funding history for miBiome Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by miBiome Therapeutics
Investment portfolio details for miBiome Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - miBiome Therapeutics
Detailed financials for miBiome Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mibiome Therapeutics Comparisons
Peer comparison for miBiome Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of miBiome Therapeutics
miBiome Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Automated genotyping services for murine cell lines are developed.
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Molecular analysis services for research and drug development are offered.
|
Detailed competitors of miBiome Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mibiome Therapeutics
Complete news archive for miBiome Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about miBiome Therapeutics
miBiome Therapeutics was founded in 2019.
miBiome Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Annual revenue of miBiome Therapeutics is $45.73K as on Mar 31, 2021.
miBiome Therapeutics specializes in genomic services, including DNA sequencing, scientific consulting, and computational analytics. They assist academics and commercial clients by delivering advanced technology for genetic research and applications. Based in Mumbai, India, the company focuses on improving accessibility and efficiency in genomics, processing samples and data to drive innovations in health and biotechnology.
miBiome Therapeutics offers DNA Reading, Scientific Consulting, and Computational Analytics.